Haemonetics
HAE
$90.20
Share price
2.90%
Change (1 day)
8.49%
Change (1 year)
Categories
Haemonetics (HAE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.25 B
According to Haemonetics's latest financial reports the company's total liabilities are $1.25 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Haemonetics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $1.11 B | 0.59% |
| 2022-03-31 | $1.11 B | 2.03% |
| 2021-03-31 | $1.08 B | 60.04% |
| 2020-03-31 | $0.68 B | 12.05% |
| 2019-03-31 | $0.60 B | 25.16% |
| 2018-03-31 | $0.48 B | -2.84% |
| 2017-03-31 | $0.49 B | -16.48% |
| 2016-03-31 | $0.59 B | -9.36% |
| 2015-03-31 | $0.65 B | -2.51% |
| 2014-03-31 | $0.67 B | -2.37% |
| 2013-03-31 | $0.69 B | 288.08% |
| 2012-03-31 | $0.17 B | 21.33% |
| 2011-03-31 | $0.14 B | -12.32% |
| 2010-03-31 | $0.16 B | 52.81% |
| 2009-03-31 | $0.10 B | -4.32% |
| 2008-03-31 | $0.11 B | 23.28% |
| 2007-03-31 | $93.08 M | -11.26% |
| 2006-03-31 | $0.10 B | -6.86% |
| 2005-03-31 | $0.11 B | -11.77% |
| 2004-03-31 | $0.12 B | -6.31% |
| 2003-03-31 | $0.13 B | 6.36% |
| 2002-03-31 | $0.12 B | -1.31% |
| 2001-03-31 | $0.12 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 7,758.02% | 🇺🇸 USA |
 Medtronic MDT | $38.84 B | 2,989.63% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $51.88 B | 4,027.24% | 🇺🇸 USA |
 Baxter BAX | $19.80 B | 1,475.68% | 🇺🇸 USA |
 Becton Dickinson BDX | $26.94 B | 2,043.09% | 🇺🇸 USA |
 Stryker Corporation SYK | $21.31 B | 1,595.87% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 425.36% | 🇺🇸 USA |
 Cerus CERS | $0.14 B | -88.52% | 🇺🇸 USA |